Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_142d981bd6c180968f769e0da8f620da http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af7aa65011b18386bb94b7e5140b64a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a95b91d3eb5a01fb9eab77c8c54f5be3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c0bb7b20b13818cbaf80dde23ce6dfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928db4a798a62feb0e4ad4d582001361 |
publicationDate |
2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120072096-A |
titleOfInvention |
Use of JPRP signaling genes IRRE1 and HHL1 for the treatment of fungal infections or meningitis |
abstract |
The present invention relates to the use of the UPR signaling genes Ire1 and Hxl1 for the treatment of fungal infections or meningitis. More particularly Cryptococcal kusu neo case of satiety's newly identified Ire1 and Hxl1 (H AC1 and X BP1 L ike gene 1) proteins and impair the function of the genes encoding them in, said new that the antibacterial or meningitis Treatment . Based on this, a candidate composition which may have a synergistic effect when co-administered with an existing antimicrobial agent or meningitis therapeutic agent may be provided with a pharmaceutical composition having a new antimicrobial or meningitis therapeutic effect. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021054786-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101683002-B1 |
priorityDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |